UK Government Evaluates Palantir's NHS Contract Amid Privacy Concerns

UK Government Evaluates Palantir's NHS Contract Amid Privacy Concerns

Synopsis

Britain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027 whether to continue the deal. Concerns about patient data privacy and reliance on a foreign supplier are central to the review. Parliamentarians have urged the government to end the contract, citing risks.

Listen to this article in summarized format

Britain is conducting a full review of its National Health Service contract with US data analytics firm Palantir, amid growing political pressure for the government to use a break clause at the end of the initial term in early 2027.

Technology minister Liz Kendall said on Tuesday the review would assess whether to extend the £330 million ($441 million) deal under ‌provisions allowing the ⁠government to ⁠continue it for up to seven years or terminate it.

"The current health secretary is reviewing every ​single aspect of that (contract) to make sure we get the right deal for Britain," Kendall ​told Times Radio, referring to concerns about patient confidentiality, public trust and reliance on a U.S. supplier.

The contract, awarded in 2023 to build a platform linking NHS ​data, runs until early 2027, when the government must ⁠decide whether ‌to extend it.

Parliamentary criticism

A parliamentary committee last week urged ministers ​to trigger the ​clause and end the contract, warning Palantir's role represents an "unacceptable ⁠point of weakness" and highlighting risks from relying on a ​small number of U.S. tech firms.

The committee said the company's ​growing role in the public sector raised concerns about dependence on overseas suppliers and the resilience of critical services, while noting officials reported benefits in areas such as waiting list management, operations and hospital discharge planning.

The deal has also drawn scrutiny because Palantir supplies software to the US military and immigration authorities, and ‌over the political views of its billionaire co-founder Peter Thiel, an early supporter of President Donald Trump.

Campaigners and unions have raised concerns ​about the handling ​of sensitive health ⁠data. Last month, the Financial Times reported NHS officials had proposed granting some external staff, including Palantir personnel, broad administrative access to identifiable patient data on parts of ​the system.

Palantir has said its software helps improve patient care and efficiency across the NHS.

Neither Palantir nor NHS England immediately responded to requests for comment.

Separately, London Mayor Sadiq Khan last month blocked a £50 million police contract with Palantir, citing concerns about value for money and whether companies' ethics should be considered in public procurement.

($1 = 0.7486 pounds)

This editorial summary reflects ET Tech and other public reporting on UK Government Evaluates Palantir's NHS Contract Amid Privacy Concerns.

Reviewed by WTGuru editorial team.